Human Insulin Market

Human Insulin Market - Global Market Share, Trends, Analysis and Forecast 2023 – 2032
Frequently asked questions about this report

The human insulin market size is expected to reach US$ 21.5 Billion by 2032.

The human insulin market is expected grow at a CAGR of 1.8% from 2023 to 2032.

The human insulin market size was estimated to be US$ 18 billion in 2022.

The global human insulin market segmented on the basis of product types, distribution channel, disease type and geography.

One of the main factors influencing the market’s growth is the rising prevalence of diabetes and obesity in the world. Due to an increase in infections, which is attributed to a sedentary lifestyle pattern, an aging population, and bad dietary practices, there is an increased need for insulin therapies.

Key human insulin market players are Eli Lilly and Company, Sanofi, Biocon Ltd., Julphar, Becton, Ypsomed AG, Dickinson and Company, Wockhardt Ltd., B. Braun Meselgen AG, Biodel Inc, and others.